Project Details
Description
Statens Serum Institut (SSI) in Denmark, The Technical University of Denmark and the EUCAST Development Laboratory (EDL) in Sweden have established a consortium to undertake the role and functions of the EURL-AMR through addressing the needs and requirements defined by the European Commission in Regulation 2022/2371.
The support will be delivered in the field of AMR in bacteria of public health relevance, and relate to reference diagnostics, reference material resources, external quality assessments, scientific advice and technical assistance, collaboration and research, monitoring, alert and support in outbreak response to bacteria resistant to antimicrobials and training. The overarching goal of this endeavour is to assess, develop and improve strategies for prevention and control of AMR in target priority pathogens.
The support will be delivered in the field of AMR in bacteria of public health relevance, and relate to reference diagnostics, reference material resources, external quality assessments, scientific advice and technical assistance, collaboration and research, monitoring, alert and support in outbreak response to bacteria resistant to antimicrobials and training. The overarching goal of this endeavour is to assess, develop and improve strategies for prevention and control of AMR in target priority pathogens.
Key findings
AMR, antimicrobial resistance, Public Health, ECDC, bacteria
| Short title | EURL-AMR |
|---|---|
| Acronym | EURL-AMR |
| Status | Active |
| Effective start/end date | 01/01/2025 → 31/12/2030 |
Collaborative partners
- Technical University of Denmark
- University of Lisbon
- Statens Serum Institut (lead)
- Clinical Microbiology Region Kronoberg / EUCAST Development Laboratory (EDL)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.